Collegium Pharmaceutical Inc reports results for the quarter ended in March - Earnings Summary

Collegium Pharmaceutical

10/05/2022 22:42

* Collegium Pharmaceutical Inc  COLL.OQ  reported quarterly
adjusted earnings of 44 cents​​ per share for the quarter ended
in March. The mean expectation of six analysts for the quarter
was for earnings of 90 cents per share.
    * Revenue fell 4.5% to $83.75 million from a year ago; 
analysts
expected $78.88 million. 
    * Collegium Pharmaceutical Inc's reported EPS for the
quarter was
a loss of 39 cents​.
    * The mean earnings estimate of analysts had fallen by
about 8.2%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Collegium Pharmaceutical Inc shares had fallen by 30.2%
this
quarter and lost 23.9% so far this year.
    * The company reported a quarterly loss of $13.07 million.
    * Wall Street's median 12-month price target for Collegium
Pharmaceutical Inc is $29.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated May 10 at 09:41 p.m.  ​All
figures in US dollars unless otherwise stated